ABILIFY MAINTENA (Otsuka America Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the ABILIFY MAINTENA drug offered from Otsuka America Pharmaceutical, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Otsuka America Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | aripiprazole |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-02-28 |
END MARKETING DATE: | 0000-00-00 |
ABILIFY MAINTENA HUMAN PRESCRIPTION DRUG Details:
Item Description | ABILIFY MAINTENA from Otsuka America Pharmaceutical, Inc. |
LABELER NAME: | Otsuka America Pharmaceutical, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2013-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59148-018_3687d391-4e13-4449-ba3b-a92d99201e99 |
PRODUCT NDC: | 59148-018 |
APPLICATION NUMBER: | NDA202971 |